What might change sentiment is the FDA giving us a break on the ridiculous red tape.
Favipiravir, used in real world settings totalling zero, has undertaken a phase 2 trial similar to Lani and is now undertaking two Phase 3 trials totaling 1,200 patients. Fair enough.
Lani, used 9 million times in real world settings, is expected to follow the same trials as Favipiravir.
Simply ridiculous.
What might change sentiment is the FDA giving us a break on the...
Add to My Watchlist
What is My Watchlist?